Brighter further strengthen the development team with Helbling as new partner

Brighter continue to strengthen the development team by selecting Helbling as new partner. In the ongoing development of Brighter One, Brighter has engaged Helbling Technik Bern AG, a global independent Swiss contract engineering, design and innovation company.

Helbling is one of the world’s leading engineering, design and development firms, which has supported companies all over the globe in developing ideas to high quality and successful products. Since more than 20 years, Helbling Technik Bern AG is supporting its clients to design, develop and bring into the market innovative medical solutions to improve day lives of individuals. In particular, Helbling’s track record excels in the development of drug delivery systems, pump systems, injection devices, hearing aids, active implants, surgical tools and integrated solutions, including wireless communication in medical devices for multinational corporate groups as well as promising start-up ventures.

– We are pleased to have found a reliable partner in Helbling, securing high precision and quality in the engineering development as well as the design transfer process into production. Helbling will work closely with our industrial design partner Veryday to achieve our high standing user requirements and quality standards”, says Brighter's CEO Truls Sjöstedt.

– The development of an innovative, intuitive and discreet solution to improve the daily life conditions of diabetics can be considered as a challenge. But as expert in the development of medical devices, I am convinced that Brighter, Veryday and Helbling have together all necessary expertize, creativity and experience in the development of high-end medical devices to face this challenge and develop the next generation of Brighter One , says Emmanuel Gremion, Head of Medical Devices and Partner of Helbling group.

        
About Brighter AB (publ)

By means of its intellectual property Brighter develops innovations for people who live with a medical condition. We develop the tools that improve the situation and every day lives of individuals. Half of Sweden’s 4.6 million households will be “connected” for home care or through mobile units within five years. Brighter’s objective is to simplify, streamline and strengthen the relationship between patients and healthcare professionals through the development of innovations in the area of digital health - a market that already today - 2015 - is valued at 160 Billion US dollars on a global basis.

The Company's shares are listed on NASDAQOMX First North/BRIG .
Visit our website and subscribe to press releases:
www.brighter.se

Certified Adviser
Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB, Per Grundström +46 (0)8 – 454 32 29, CorporateFinance@remium.com , www.remium.com .

For further information, please contact:

Henrik Norström, COO
Telephone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
Truls Sjöstedt, VD
Telephone : +46 709 73 46 00
Email: truls.sjostedt@brighter.se

Tags:

About Us

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first innovative tool Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

Subscribe

Documents & Links